Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANGOCIN Anti-Infekt N versus placebo in adult patients with acute bronchitis
2018-001395-37Phase 4Completed
- Sponsor
- Repha
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute bronchitis comparing ANGOCIN Anti-Infekt N with Placebo (2 arms). Primary endpoint: Change in mean BSSinv from baseline to Day 7. Started Jun 2018; status: completed.
02
Drugs
Angocin Anti-Infekt N
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on 2018-001395-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001395-37.